Ең жақсы простата рагының дәрігерлері - ЖОҒ-135 дәрігерлер

Urologist

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Dr. Harald Rosen is a leading abdominal surgeon. He specializes in endocrine, gastrointestinal, liver, colon, and bariatric surgeries. His expertise includes complex procedures such as sleeve gastrectomy and gastric anastomosis. Dr. Rosen is known for his research on improving the quality of life for rectal cancer patients after surgery. He also has a strong academic background in surgical oncology, with a focus on gastroenterology and breast cancer.

Dr. Rosen is President of the European Society of Surgery. He is also a Professor of Surgery at Vienna Medical School. He is accredited by the European Council for Surgical Qualifications and the Austrian Medical Council. Dr. Rosen has performed over 5,000 advanced surgeries with excellent results. He has published widely and is often invited as a visiting professor around the world.

Prof. Dr. Markus Heuser is an urologist and pediatric urologist, with 24 years of medical practice. He specializes in the diagnosis and treatment of diseases of the urinary system and male genitalia, andrology, and cancer treatment. Dr. Heuser has published over 40 scientific articles and is recognized for his expertise in special urological surgery and drug treatment of tumors.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Oncologist, Oncohematologist, Surgeon

Head physician of Oncology and Hematology Center

Prof. Elke Jaeger is one of the best German doctors according to Focus rating.

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

Dr. Axel Stang is a professor, Head Physician of Asklepios Barmbek Clinic, with a specialization in internal medicine, oncology, and hematology. He conducts antibody and molecular therapies to reduce tumor size, and is a member of multiple organizations and societies. Dr. Stang has published articles on the effectiveness of radiofrequency ablation in treating of metastatic colon cancer, and was a member of a research group that studied the effects of liver embolization. Patients can submit a request on the Bookimed website to get a consultation with the professor.

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Professor Nadia Di Muzio is a Head of the Radiotherapy Department in the San Raffaele Research Hospital in Milan since 2008. She has a degree in general medicine and surgery and specialty in oncological radiotherapy from the University of Milan and has done an internship at the Department of Radiation Oncology in the University of Madison. Professor Di Muzio is an author of 200 studies in radiation oncology research and an advocate of high-precision hypofraction methods in the radical treatment of prostate tumors. She currently holds positions in the Italian Association of Medical Oncology, the Italian Society of Oncological Urology and the European Society for Radiotherapy and Oncology.

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.